Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-Ala-D-Ala moiety is a dipeptide composed of two D-alanine residues. It forms the C-terminal end of the peptide stem attached to N-acetylmuramic acid (MurNAc) in peptidoglycan precursor subunits, which are essential building blocks for bacterial cell wall synthesis. It is a crucial substrate for transpeptidase enzymes, and a target for antibiotics like vancomycin.
Vancomycin binds directly to the D-Ala-D-Ala moiety, blocking transpeptidases. β-lactam antibiotics inhibit penicillin-binding proteins (transpeptidases) that interact with D-Ala-D-Ala.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-Alanyl-D-Alanine (D-Ala-D-Ala).